Rosacea

Topical metronidazole has been used for the treatment of rosacea for over 30 years. Several placebo-controlled trials have demonstrated its effectiveness in the treatment of moderate-to-severe rosacea.

Many options exist for the treatment of rosacea, including topical and systemic therapies, laser and light-based therapies, and surgical procedures. The goals of therapy include reduction of papules, pustules, erythema, physical discomfort, and an improvement in quality of life.

Tetracycline is a broad spectrum antibiotic that is often used to treat acne and roscaea for its antibacterial and anti-inflammatory effects. Mechanism of action, drug interactions, and side-effects are discussed.

ROSASOL Cream is a novel topical formulation of 1% metronidazole in a vehicle containing sunscreens (SPF 15). This product has demonstrated efficacy in the treatment of inflammatory lesions, erythema, and telangiectasiae associated with rosacea.

Use of azelaic acid was associated with a significant reduction in inflammatory lesions, which persisted beyond the active treatment phase. Overall, azelaic acid 15% gel is an appropriate initial topical therapy for the treatment of moderate facial rosacea.

Metronidazole is a nitroimidazole that has antibiotic and antiprotozoal effects. Mechanism of action, side-effects both local and systemic, brands, and drug interactions are discussed.

This articles focuses on a common symptom of rosacea - telangiectasia, and treatment options that are available, such as laser therapy.

Novel uses of old medications and new formulations of systemic medications have broadened the therapeutic armamentarium for treating rosacea patients. It is of primary importance to offer patients safe and effective therapies for this chronic and incurable condition, improving both the clinical and psychosocial consequences of rosacea.

This review details the rosacea phenotype approach to diagnosis and classification, and summarizes current evidence-based treatment recommendations for individual features.

Rosacea is a common chronic skin disorder that has significant impact on the quality of life of affected individuals. Research interest has led to the development of other emerging therapies including topical ivermectin, brimonidine and oxymetazoline that hold promise for patients suffering from this condition.

Erythromycin is an antibiotic in the macrolide group, and is often used in acne treatment, but also rosacea treatment. Mechanism of action, side-effects, brands and drug interactions are discussed.

This article reviews the various subtypes of rosacea, their clinical presentations, and the considerations in choosing the optimal therapeutic options. The importance of tailored treatment is discussed as well as topical therapies.

A triad approach to the treatment of acne and rosacea has been recommended. This integrated management approach includes patient education, selection of therapeutic agents, and initiation of an appropriate skin care regime. Appropriate skin care recommendations for patients with acne and rosacea will be discussed.

The etiology of papulopustular rosacea (PPR) is not well understood yet appears to involve both the innate and adaptive immune response in addition to possible infestation with Demodex mites. This article reviews data on Ivermectin cream 1%, a new topical treatment for PPR.

Rosacea is a common condition that affects people of all races. More aggressive and innovative uses of existing oral agents have resulted in novel therapeutic approaches, which can provide long-term therapy and sustained remission.

Isotretinoin, better known by its trade name Accutane®, and its side-effects are discussed with an emphasis on the most common side-effects that patients reports, such as dryness of the skin, and irritation of the eyes.

Clinical rosacea is not a single disease but rather a combination of cutaneous stigmata which include flushing, erythema, telangiectasia, facial edema, papules, pustules, ocular lesions, and rhinophyma. A review of rosacea, treatment, and management.

Rosacea is a common, chronic cutaneous condition that affects the face. Various conventional and emerging therapies for rosacea are reviewed.

Sodium sulfacetamide is used to treat rosacea as well as acne, seborrheic dermatitis. This article discusses the interactions of drugs, brands, and side-effects.

Rhinophyma describes the growth of the nose in some patients with rosacea. This article describes the condition, its demographics, and treatments for rhinophyma.

There are currently no laboratory tests to diagnose rosacea; it remains a clinical diagnosis. The actual pathophysiology and etiology of rosacea also remain unclear; however, quite recently the spectrum of rosacea has been classified and standardized.

Azelaic acid is a naturally occurring dicarboxylic acid that is found in grain and is used to treat rosacea. Medication use, side-effects, and brands are discussed.

Rosacea is a common, chronic cutaneous condition that affects the face. This article reviews a variety of treatments for treatments for rosacea, including topical and systemic therapies.

Isotretinoin (Accutane®) is a retinoid or vitamin A analog, and most well known for its use in treating severe acne. This article discusses the case for use in treating rosacea, and what expectations patients should have.

Treatment options of rosacea, starting from lifestyle, prevention, cosmetics, and patient support groups are discussed as well as medical treatment options.

Rosacea is relatively common, typically occurring in individuals of Northern European and Celtic origin between 30 and 50 years of age. It is more common in women, but may be more severe in men. Currently there is no cure available for rosacea, but it can be controlled with topical and oral drug therapy.

Isotretinoin (Accutane) is a powerful drug, but one that has powerful side-effects. This article focuses on the side-effects that require monitoring as the symptoms may not be obvious to the patients.